RE:RE:RE:The delayed newsletterAmen CAinPlap, it's a similar concern that I have posted several times over the past years! ...and the pharma with much revenue at risk is wise in how they deploy the roadblocks...many medical/regulatory folks in high positions on the dole, directly or indirectly (disguised). Like you said, too many billions at risk for some of the 'pill pushers' to simply sit back and watch. The will spend a few million here and there to protect many billions, that's for sure!
CAinPlap wrote: Now I'm curious as to what company that was from.
It is that sentiment (profits first, humanity second at best) that has always made me wonder how many hurdles will be put in our path. If my overly simplistic view is correct that if/when this works on bladder cancer, it is only a matter of tweaking the pdt delivery and light delivery to other cancers, then I suspect there will be no punches pulled by Big pharma in protecting there existing billions in annual revenue from existing treatments. Even delaying a cure for a few months/years is worth huge dollars.